OligoCard for DNA Sequencing
ID: N0017323P3215Type: Justification
AwardedJan 9, 2023
Award #:N0017323P3215
Overview

Buyer

DEPT OF DEFENSEDEPT OF THE NAVYNAVAL RESEARCH LABORATORYWASHINGTON, DC, 20375-5328, USA

PSC

IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS (6550)
Timeline
    Description

    The Department of Defense, specifically the Naval Research Laboratory (NRL), is seeking a sole-source procurement of OligoCards from Integrated DNA Technologies (IDT) for critical research purposes. This acquisition, valued between $10,000 and $250,000, is justified under FAR 13.106-1(b)(1)(i) due to the urgent need for specialized oligonucleotides and comprehensive sequencing services that only IDT can provide. The OligoCards are vital for advancing molecular biology, biotechnology, and DNA nanotechnology research, particularly in areas such as protein production, threat detection, and sensor development for the Department of Defense. Interested parties can reach out to Brandon Zellers at brandon.zellers@nrl.navy.mil for further information regarding this opportunity.

    Point(s) of Contact
    Files
    Title
    Posted
    The U.S. Department of Navy's Naval Research Laboratory (NRL), Code 6900, requires a sole-source procurement of OligoCards from Integrated DNA Technologies (IDT). This acquisition, exceeding $10,000 but under $250,000, is justified under FAR 13.106-1(b)(1)(i) due to the urgent and exclusive nature of IDT's offerings. The OligoCards are essential for molecular biology, biotechnology, and DNA nanotechnology research, enabling critical work on protein production for DoD, threat detection, and sensor development. IDT is the only vendor capable of meeting the stringent requirements, including specialized oligonucleotides, gene fragments, and comprehensive sequencing services (Sanger, whole genome, amplicon, RNA-Seq) across various platforms (Illumina, PacBio, MinION/GridION), with a crucial 24-hour turnaround. This rapid delivery is vital to prevent research halts and missed deadlines, particularly for critical Navy Laboratory research on novel biothreats impacting warfighter safety.
    Lifecycle
    Title
    Type
    Similar Opportunities
    Eurofin's EvoCard for DNA Sequencing
    Dept Of Defense
    The Department of Defense, specifically the Naval Research Laboratory (NRL), is seeking to procure EVOcards from Eurofins Genomics through a sole-source acquisition due to urgent and compelling needs. These EVOcards are essential for acquiring oligonucleotides, synthesized genes, and sequencing reactions, which are critical for ongoing research in molecular biology, biotechnology, and DNA nanotechnology. The NRL requires a rapid 24-hour turnaround for these specialized products to avoid disruptions in vital research related to biothreats and emerging diseases, with Eurofins identified as the only viable source capable of meeting this requirement. For further inquiries, interested parties can contact Brandon Zellers at brandon.zellers@nrl.navy.mil.
    TRITON AUTOMATED NUCLEIC ACID EXTRACTION DEVICE AND CARTRIDGE
    Dept Of Defense
    The Department of Defense, through the Naval Research Laboratory, is soliciting quotes for the purchase of a TRITON Automated Nucleic Acid Extraction Device and 25 TRITON Cartridges, specified as 'Brand Name Only' from Triton Genomics Incorporated. This procurement is set aside for Women-Owned Small Businesses (WOSB) and is critical for enhancing laboratory capabilities in nucleic acid extraction, which is essential for various research and defense applications. Interested vendors must submit their quotations by January 12, 2026, with an expected delivery date of January 30, 2026. For further inquiries, Richard Key can be contacted via email at richard.a.key2.civ@us.navy.mil.
    NOTICE of Intent to SOLE SOURCE - Biolytic Lab Performance INC
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Centers for Disease Control and Prevention (CDC), intends to award a sole source firm fixed price purchase order to Biolytic Lab Performance INC for the maintenance and upkeep of Dr. Oligo 48 Medium Throughput DNA Synthesizers. This procurement is critical for ensuring the operational readiness of a laboratory instrument that plays a vital role in standard laboratory operations and public health emergencies, necessitating regular maintenance and access to proprietary codes and OEM parts. Biolytic is uniquely qualified to provide these services due to their trained engineers and exclusive access to genuine OEM parts, with a response time of 24-48 hours for service calls. Interested parties may submit their interest and capability to respond to this requirement via email to the contract specialist by COB January 22, 2026, although this notice is not a request for competitive quotations.
    Brand Name Illumina reagents, kits and consumables (BPA)
    Dept Of Defense
    The Department of Defense, through the Defense Health Agency (DHA), intends to issue a sole source contract for the procurement of brand name Illumina reagents, kits, and consumables, specifically to Bio-Active Co., Ltd in Thailand. This procurement aims to support high-throughput sequencing workflows that are critical for microbial surveillance, viral detection, influenza typing, and gene expression profiling, utilizing products that are validated for compatibility with Illumina sequencing platforms. Interested parties are invited to respond within 15 days with evidence of their ability to provide comparable services; otherwise, the contract will be awarded solely to the identified vendor. For further inquiries, interested parties may contact John Fitzsimmons at john.l.fitzsimmons8.civ@health.mil or by phone at 301-514-2040.
    Comprehensive full-service maintenance/repair plan for Illumina Nova/Seq 6000
    Dept Of Defense
    The Department of Defense, through the Naval Medical Research Center (NMRC), is seeking to award a sole-source contract to Illumina, Inc. for a comprehensive maintenance and repair plan for the Illumina NovaSeq 6000 sequencing instrument. The contract, valued at $145,522, requires full coverage for OEM parts and labor, no-cost replacement of proprietary reagents, one on-site preventative maintenance visit, remote technical support, and on-site response within two business days, among other services. This procurement is critical for maintaining the operational integrity of the NovaSeq 6000, which is essential for various research applications. Interested parties may contact Deborah Sharpe at deborah.m.sharpe2.civ@health.mil or Stephanie Gray at stephanie.r.gray4.civ@health.mil for further information.
    CareDX Lab Solutions Inc. Allo Seq Tx17 Next Generation Sequencing (NGS) Reagent Kits
    Health And Human Services, Department Of
    The National Institutes of Health (NIH) intends to issue a sole-source firm fixed-price purchase order to CareDx Lab Solutions Inc. for the procurement of Allo Seq Tx17 Next Generation Sequencing (NGS) reagent kits. This acquisition aims to secure a one-year supply of NGS reagents necessary for the Human Leukocyte Antigen (HLA) Laboratory within the Department of Transfusion Medicine, ensuring adequate stock for patient testing through quarterly shipments scheduled for February, May, and August 2026. The HLA Laboratory plays a critical role in providing diagnostic testing and consultations for transplant eligibility, maintaining accreditation, and engaging in research for new diagnostic tests. Interested parties may submit their capability statements to Shasheshe Goolsby at shasheshe.goolsby@nih.gov by January 10, 2026, at 6:00 AM EST, as this is not a request for proposals.
    Thorlabs Infrared Spectrum Analyzer
    Dept Of Defense
    The Department of Defense, through the Naval Research Laboratory (NRL), intends to award a sole source contract to Thorlabs Inc. for the procurement of a Thorlabs Infrared Spectrum Analyzer. This specialized analytical laboratory instrument is critical for the NRL's research and development efforts, and the purchase will be made under Simplified Acquisition Procedures, adhering to FAR Part 13.106-1(b) for transactions not exceeding $250,000. Interested parties may express their capability to fulfill this requirement, but the government retains discretion over whether to pursue competitive procurement based on the responses received. For inquiries, contact James Chappell at james.chappell@nrl.navy.mil or call 202-923-1418, referencing Notice of Intent number N00173-26-Q-1301265113.
    Assessment of Host-targeted Nanobody Therapeutics
    Dept Of Defense
    The Department of Defense, through the Defense Health Agency (DHA), is seeking contractors for an Indefinite Delivery/Indefinite Quantity (IDIQ) contract focused on the assessment of host-targeted nanobody therapeutics. The primary objective is to evaluate and refine nanobody therapies using established in vitro porcine blood-brain barrier (BBB) models, develop novel BBB models, and address the challenges of delivering therapeutic payloads into the Central Nervous System (CNS) for neurotropic viral infections. This initiative is critical for advancing therapeutic options against high-priority pathogens, as it aims to overcome the limitations posed by the blood-brain barrier. Interested contractors can contact Grant A. Gratton at grant.a.gratton.civ@health.mil or Emily K. O'Hara at emily.k.ohara.civ@health.mil for further details, with the contract having a five-year ordering period and performance monitored through a Quality Assurance Surveillance Plan (QASP).
    NRL NOTICE OF INTENT TO AWARD SOLE SOURCE QXDM Subscription/License
    Dept Of Defense
    The Naval Research Laboratory (NRL), part of the Department of Defense, intends to award a sole source contract to Qualcomm Technologies, Inc. for a QXDM 2-5G Yearly License Subscription and an Annual Software License Fee. This procurement, categorized under NAICS code 541519 and PSC code 7A21, is essential for supporting advanced telecommunications and software applications within the Navy's operational framework. The contract will be executed using Simplified Acquisition Procedures, as the total value does not exceed the $250,000 threshold, and interested parties may submit evidence of their capabilities for consideration. For further inquiries, interested vendors can contact Carrie Cawley at carrie.a.cawley.civ@us.navy.mil or Katrina Gallagher at katrina.t.gallagher.civ@us.navy.mil.
    66--TEST KIT, LP
    Dept Of Defense
    The Department of Defense, specifically the Department of the Navy, is seeking to procure two test kits under the presolicitation notice titled "66--TEST KIT, LP." The procurement involves the delivery of these kits to designated distribution centers in New Cumberland, PA, and Tracy, CA, with the Government indicating that the rights to use the necessary data for purchasing or repairing this part from additional sources are not owned by them, making reverse engineering uneconomical. This procurement is critical for ensuring the availability of specialized electrical and electronic properties measuring and testing instruments, which play a vital role in defense operations. Interested parties are encouraged to contact Danielle Dell Isola at (771) 229-0057 or via email at DANIELLE.DELLISOLA@NAVY.MIL for further details, and they have 45 days to express their interest or submit proposals following the notice publication.